Market Trends– category –
-
Nanocomposite Advanced Materials Market Projected to Reach $60 Billion by 2034 (Market.us Report)
Market.us USA Overview A new report by Market.us forecasts the Nanocomposite Advanced Materials market to grow from $32 billion in 2025 to $60 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 7.2%. This robust growth i... -
Nanoco Group PLC Initiates Shareholder Consultation Following Delisting Vote Postponement to Rethink CFQD® Strategy
TradingView / London Stock Exchange (RNS) UK Overview Nanoco Group PLC has postponed its general meeting for delisting approval and appointed Sodali & Co. to deepen shareholder engagement. This consultation aims to re-evaluate the fu... -
First Graphene Acquires MITO, Targets US Defense Market with Over $10M PureGRAPH® Revenue Pipeline
Kalkine Australia Overview First Graphene Limited has acquired MITO Material Solutions to accelerate its expansion into the US defense, aerospace, transportation, and advanced materials markets. The company has identified a short-term re... -
Chinese Startup Prinano Claims Mass Production of 8-inch Photonic Chip Wafers Using Nanoimprint Lithography, Projecting Up to 90% Cost Reduction
New Market Pitch China Overview According to a New Market Pitch analysis, Chinese startup Prinano claims successful mass production of 8-inch photonic chip wafers using nanoimprint lithography (NIL), without conventional DUV lithography.... -
Big Pharma’s Nanotech Bet: Pfizer, Moderna, AstraZeneca Spearhead LNP Drug Delivery Revolution, Says DataM Intelligence
DataM Intelligence International Overview A new market research report from DataM Intelligence highlights the leading companies shaping the nanotechnology drug delivery landscape. The study reveals that pharmaceutical and biotechnology g... -
Strategic Capital Influx in Gene Therapy: Pfizer Invests in CRISPR Biotech, AstraZeneca Strengthens China Cell Therapy Capabilities
BioPharma Dive USA Overview The gene therapy sector is experiencing a surge in strategic funding and M&A activities from major pharmaceutical companies. Pfizer has invested in CRISPR biotech Caribou Biosciences, while AstraZeneca pla... -
Biopharma M&A Accelerates in H1 2026: Eli Lilly Leads with Over $25 Billion Spend as Big Pharma Bolsters Pipelines
BioPharma Dive USA Overview Biopharmaceutical M&A activity significantly accelerated in the first half of 2026, with over 50 deals transacted. Eli Lilly was notably active, spending over $25 billion and solidifying its position as a ... -
Europe’s Biotech Vanguard: Automated, Closed Systems Drive Next-Gen CGT Manufacturing and Decentralized Access
PharmTech.com ヨーロッパ Overview European biotechnology firms are pioneering next-generation manufacturing technologies for cell and gene therapies (CGT), centered on automated, closed systems. These innovations, exemplified by companie... -
BioNetwork Consulting Introduces Agentic AI for Clinical Operations, Offering Expertise in Gen AI Governance and Real-World Evidence Strategy
BioNetwork Consulting USA Overview BioNetwork Consulting now offers specialized expertise in integrating Agentic AI into Clinical Operations, with a strong focus on Generative AI (Gen AI) Governance & Regulatory Compliance, and Real-... -
Kanerika Unveils Custom LLM Development Services for Enterprises, Emphasizing Robust Governance and Compliance for Regulated Industries
Kanerika India Overview Kanerika has launched custom LLM development services for enterprise teams, with a strong focus on enterprise-grade governance and compliance for regulated industries. Their solutions feature a governed LLM archit...
